Clinical Trial Detail

NCT ID NCT02997228
Title Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer
Recruitment Suspended
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Atezolizumab

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Atezolizumab + Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.